Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
120,192,308
-
Total 13F shares
-
44,051,858
-
Share change
-
+840,388
-
Total reported value
-
$127,751,172
-
Put/Call ratio
-
409%
-
Price per share
-
$2.90
-
Number of holders
-
120
-
Value change
-
-$2,587,454
-
Number of buys
-
72
-
Number of sells
-
47
Institutional Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q1 2025
As of 31 Mar 2025,
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) was held by
120 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,051,858 shares.
The largest 10 holders included
Bratton Capital Management, L.P., BlackRock, Inc., VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, STATE STREET CORP, Pale Fire Capital SE, BANK OF AMERICA CORP /DE/, and Janney Montgomery Scott LLC.
This page lists
120
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.